DAVENPORT & Co LLC lessened its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 9.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 865,064 shares of the enterprise software provider's stock after selling 91,578 shares during the quarter. Oracle accounts for 1.0% of DAVENPORT & Co LLC's investment portfolio, making the stock its 13th biggest position. DAVENPORT & Co LLC's holdings in Oracle were worth $187,602,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also modified their holdings of the stock. Brighton Jones LLC grew its position in Oracle by 189.3% in the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider's stock valued at $25,593,000 after acquiring an additional 100,494 shares in the last quarter. Revolve Wealth Partners LLC grew its holdings in Oracle by 8.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider's stock valued at $903,000 after purchasing an additional 404 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in Oracle by 5.0% during the 1st quarter. Sivia Capital Partners LLC now owns 3,580 shares of the enterprise software provider's stock valued at $501,000 after purchasing an additional 171 shares in the last quarter. UMB Bank n.a. lifted its holdings in Oracle by 1.0% in the 1st quarter. UMB Bank n.a. now owns 215,074 shares of the enterprise software provider's stock worth $30,069,000 after buying an additional 2,217 shares in the last quarter. Finally, Whitaker Myers Wealth Managers LTD. purchased a new position in Oracle in the 1st quarter valued at about $515,000. Institutional investors and hedge funds own 42.44% of the company's stock.
Oracle Stock Performance
Shares of ORCL opened at $286.23 on Monday. The stock has a market capitalization of $815.99 billion, a PE ratio of 66.26, a price-to-earnings-growth ratio of 3.08 and a beta of 1.53. The business's fifty day moving average price is $262.53 and its 200 day moving average price is $205.85. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72.
Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. During the same period last year, the company posted $1.39 earnings per share. The firm's revenue for the quarter was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts forecast that Oracle Corporation will post 5 EPS for the current year.
Oracle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. Oracle's dividend payout ratio is 46.30%.
Insider Buying and Selling
In related news, insider Michael D. Sicilia sold 33,845 shares of the firm's stock in a transaction that occurred on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the sale, the insider owned 132,656 shares of the company's stock, valued at approximately $42,603,800.96. This trade represents a 20.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director William G. Parrett sold 11,500 shares of the business's stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $306.00, for a total value of $3,519,000.00. Following the transaction, the director owned 17,764 shares of the company's stock, valued at $5,435,784. This represents a 39.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 104,314 shares of company stock valued at $31,272,223 over the last quarter. Company insiders own 40.90% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on ORCL. Sanford C. Bernstein lifted their target price on Oracle from $363.00 to $364.00 and gave the stock an "outperform" rating in a research report on Friday, September 26th. Raymond James Financial restated a "strong-buy" rating on shares of Oracle in a report on Wednesday, June 18th. UBS Group set a $364.00 target price on Oracle in a research note on Friday, September 26th. Bank of America upgraded shares of Oracle from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $295.00 to $368.00 in a research note on Wednesday, September 10th. Finally, Westpark Capital upped their price target on shares of Oracle from $195.00 to $246.00 and gave the company a "buy" rating in a report on Thursday, June 12th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $304.71.
Check Out Our Latest Analysis on Oracle
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report